Cost Effectiveness of TNF-𝛼 Inhibitors in Rheumatoid Arthritis

Table 6

Statistical analysis between the choice of health outcome used to express ICERs.

Health benefit outcome	Mean (€)	P value	SD
HAQ	1976.469		1860.4
DAS-28	2086.469	0.789	837.3
SF-6D	2316.376		869.3

The level of significance (significance noted at 𝑃<0.05) and standard deviations between the HAQ, DAS-28, and the SF-6D.